IBDEI1EL ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25164,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25164,1,4,0)
 ;;=4^386.30
 ;;^UTILITY(U,$J,358.3,25164,1,5,0)
 ;;=5^Labyrinthitis NOS
 ;;^UTILITY(U,$J,358.3,25164,2)
 ;;=^67891
 ;;^UTILITY(U,$J,358.3,25165,0)
 ;;=088.81^^145^1536^42
 ;;^UTILITY(U,$J,358.3,25165,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25165,1,4,0)
 ;;=4^088.81
 ;;^UTILITY(U,$J,358.3,25165,1,5,0)
 ;;=5^Lyme Disease
 ;;^UTILITY(U,$J,358.3,25165,2)
 ;;=^72315
 ;;^UTILITY(U,$J,358.3,25166,0)
 ;;=785.6^^145^1536^43
 ;;^UTILITY(U,$J,358.3,25166,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25166,1,4,0)
 ;;=4^785.6
 ;;^UTILITY(U,$J,358.3,25166,1,5,0)
 ;;=5^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,25166,2)
 ;;=^72368
 ;;^UTILITY(U,$J,358.3,25167,0)
 ;;=031.0^^145^1536^44
 ;;^UTILITY(U,$J,358.3,25167,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25167,1,4,0)
 ;;=4^031.0
 ;;^UTILITY(U,$J,358.3,25167,1,5,0)
 ;;=5^Mycobacteria,Atyp,Pulmonary
 ;;^UTILITY(U,$J,358.3,25167,2)
 ;;=^101018
 ;;^UTILITY(U,$J,358.3,25168,0)
 ;;=730.00^^145^1536^46
 ;;^UTILITY(U,$J,358.3,25168,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25168,1,4,0)
 ;;=4^730.00
 ;;^UTILITY(U,$J,358.3,25168,1,5,0)
 ;;=5^Osteomyelitis,Acute Unsp
 ;;^UTILITY(U,$J,358.3,25168,2)
 ;;=^272612
 ;;^UTILITY(U,$J,358.3,25169,0)
 ;;=730.10^^145^1536^47
 ;;^UTILITY(U,$J,358.3,25169,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25169,1,4,0)
 ;;=4^730.10
 ;;^UTILITY(U,$J,358.3,25169,1,5,0)
 ;;=5^Osteomyelitis,Chron Unsp
 ;;^UTILITY(U,$J,358.3,25169,2)
 ;;=^24427
 ;;^UTILITY(U,$J,358.3,25170,0)
 ;;=380.10^^145^1536^48
 ;;^UTILITY(U,$J,358.3,25170,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25170,1,4,0)
 ;;=4^380.10
 ;;^UTILITY(U,$J,358.3,25170,1,5,0)
 ;;=5^Otitis Externa 
 ;;^UTILITY(U,$J,358.3,25170,2)
 ;;=380.10^62807
 ;;^UTILITY(U,$J,358.3,25171,0)
 ;;=382.9^^145^1536^49
 ;;^UTILITY(U,$J,358.3,25171,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25171,1,4,0)
 ;;=4^382.9
 ;;^UTILITY(U,$J,358.3,25171,1,5,0)
 ;;=5^Otitis Media
 ;;^UTILITY(U,$J,358.3,25171,2)
 ;;=^123967
 ;;^UTILITY(U,$J,358.3,25172,0)
 ;;=614.9^^145^1536^50
 ;;^UTILITY(U,$J,358.3,25172,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25172,1,4,0)
 ;;=4^614.9
 ;;^UTILITY(U,$J,358.3,25172,1,5,0)
 ;;=5^Pelvic Inflammatory Disease
 ;;^UTILITY(U,$J,358.3,25172,2)
 ;;=^3537
 ;;^UTILITY(U,$J,358.3,25173,0)
 ;;=486.^^145^1536^52
 ;;^UTILITY(U,$J,358.3,25173,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25173,1,4,0)
 ;;=4^486.
 ;;^UTILITY(U,$J,358.3,25173,1,5,0)
 ;;=5^Pneumonia
 ;;^UTILITY(U,$J,358.3,25173,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,25174,0)
 ;;=136.3^^145^1536^51
 ;;^UTILITY(U,$J,358.3,25174,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25174,1,4,0)
 ;;=4^136.3
 ;;^UTILITY(U,$J,358.3,25174,1,5,0)
 ;;=5^Pneumocystosis
 ;;^UTILITY(U,$J,358.3,25174,2)
 ;;=^95635
 ;;^UTILITY(U,$J,358.3,25175,0)
 ;;=601.9^^145^1536^56
 ;;^UTILITY(U,$J,358.3,25175,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25175,1,4,0)
 ;;=4^601.9
 ;;^UTILITY(U,$J,358.3,25175,1,5,0)
 ;;=5^Prostatitis NOS
 ;;^UTILITY(U,$J,358.3,25175,2)
 ;;=^99489
 ;;^UTILITY(U,$J,358.3,25176,0)
 ;;=590.80^^145^1536^57
 ;;^UTILITY(U,$J,358.3,25176,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25176,1,4,0)
 ;;=4^590.80
 ;;^UTILITY(U,$J,358.3,25176,1,5,0)
 ;;=5^Pyelonephritis NOS
 ;;^UTILITY(U,$J,358.3,25176,2)
 ;;=^101463
 ;;^UTILITY(U,$J,358.3,25177,0)
 ;;=711.00^^145^1536^58
 ;;^UTILITY(U,$J,358.3,25177,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25177,1,4,0)
 ;;=4^711.00
 ;;^UTILITY(U,$J,358.3,25177,1,5,0)
 ;;=5^Septic Joint
 ;;^UTILITY(U,$J,358.3,25177,2)
 ;;=^263780
